16.01.2015 Views

Policy Roundtable Abstracts - AcademyHealth

Policy Roundtable Abstracts - AcademyHealth

Policy Roundtable Abstracts - AcademyHealth

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

care services and financing, cost containment, and<br />

emerging policy issues.<br />

IMPACT These states vary by geography,<br />

political and policy environments, and health care<br />

markets, but the individuals are all leaders in driving<br />

health policy broadly and in thinking through the issues<br />

around developing an exchange. They represent<br />

different positions in state government. They have all<br />

agreed to participate on the panel, but given their key<br />

roles as policymakers, their availability is subject to<br />

change. Clearly, they are forging new ground, and<br />

through this panel they will provide valuable evidence<br />

and expertise on early lessons learned that will go far to<br />

assist all states and policymakers as they move forward<br />

with implementation of health reform.<br />

Identifying, Monitoring, and Evaluating Promising<br />

Payment and Delivery System Innovations<br />

Organizer/Moderator: Stuart Guterman<br />

Sunday, June 12 * 4:30 p.m.–6:00 p.m.<br />

Panelists: Marsha Gold, Sc.D.,M.P.H., Mathematica<br />

<strong>Policy</strong> Research; Lawrence PCasalino, M.D.,Ph.D.,<br />

Weill Cornell Medical College; Randall Brown, Ph.D.,<br />

Mathematica <strong>Policy</strong> Research, Inc.; Paul Wallace, M.D.;<br />

The Permanente Federation, LLC.<br />

<strong>Roundtable</strong> Summary: The national health reform<br />

legislation includes a multitude of new demonstrations<br />

and pilots to cut costs and increase quality in our health<br />

care system. As Atul Gawande notes in his recent<br />

article, “Testing, Testing”, health reform legislation<br />

“contains a test of almost every approach that leading<br />

healthcare experts have suggested” for improving health<br />

care financing and delivery.<br />

One of the principal reasons for why we have<br />

yet to implement the many ideas being proposed to<br />

reform the current delivery system is that we lack<br />

sufficient information on how the proposed<br />

organizational and financing reforms would work in<br />

practice. To address this knowledge gap, the Patient<br />

Protection and Affordable Care Act signed into law in<br />

March 2010 establishes Center for Medicare and<br />

Medicaid Innovation (CMMI) within the Centers for<br />

Medicare and Medicaid Services (CMS). This new<br />

center will facilitate the development of pilot projects and<br />

propose strategies to disseminate and promote the<br />

uptake of successful delivery system reforms. As Stuart<br />

Altman and Robert Mechanic note in a recent article in<br />

the New England Journal of Medicine, a key difference<br />

of demonstrations developed under the Innovation<br />

Center from previous Medicare-sponsored<br />

demonstrations is the Secretary of Health and Human<br />

Services’ new authority to expand pilot programs that<br />

successfully reduce costs or improve the quality of care.<br />

In a recent analysis of the prior challenges that<br />

have arisen when demonstration projects were used to<br />

inform policy, Stuart Guterman and Heather Drake of the<br />

Commonwealth Fund note that prior demonstration<br />

programs were hampered in their ability to move from<br />

testing innovations to their broader application in<br />

practice due to “limitations in the methodology and data<br />

available to conduct comprehensive evaluations of<br />

demonstrations projects” and “insufficient resources for<br />

developing, implementing, monitoring, and evaluating<br />

demonstration projects.” In this session, a panel of<br />

experts with a variety of perspectives will address the<br />

problems identified with moving from the pilot or<br />

demonstration phase to broader program<br />

implementation, including limitations in methods for<br />

assessing and evaluating promising interventions. This<br />

session will include a presentation by Marsha Gold of a<br />

paper she is preparing on this topic, and a panel<br />

discussion of the methodological issues related to<br />

identifying, monitoring, and evaluating promising<br />

payment and delivery system innovations, and the<br />

contribution that the health services research community<br />

can make to this process.<br />

The panel will assess and seek to identify<br />

solutions on the following five critical areas:<br />

1) Criteria used to prioritize innovations that merit an<br />

investment in evaluation and scale up<br />

2) Best practices in the design and implementation of<br />

the pilot intervention itself,<br />

3) Best practices in the design of evaluations<br />

4) Criteria for judging success<br />

5) Strategies for scaling up successful pilots<br />

As Guterman and Drake conclude in their paper, the<br />

success of the Center will depend upon its ability “to<br />

develop reliable methods for monitoring and evaluating<br />

pilot projects and analyzing the applicability of various<br />

aspects of individual pilots for implementation in different<br />

combinations and settings.” Anticipating that<br />

policymakers will need clear direction for meeting the<br />

ambitious goals set for the new CMS Innovation Center,<br />

this project will seek to resolve the inherent conflict<br />

between making quick assessments of promising<br />

innovations and the need to provide compelling evidence<br />

that the project would improve quality and or reduce<br />

cost.<br />

Potential topics for the panel members to discuss<br />

include the following:<br />

What criteria should be considered in selecting an<br />

innovation that merits evaluation<br />

What do we need to keep in mind about the<br />

evaluation design and methods For example:<br />

Should evaluation criteria include both quality and<br />

cost measures<br />

o How is context considered in the<br />

o<br />

design<br />

How do we move beyond randomized<br />

trials to explore relationships of<br />

causality<br />

What constitutes success and when and how should<br />

pilots be scaled up<br />

How do we turn what gets learned from pilots into<br />

system-wide policy<br />

The panel moderator and leader of the discussion will<br />

be: Stuart Guterman, vice president for Payment and<br />

System Reform at The Commonwealth Fund and<br />

executive director of the Fund’s Commission on a High<br />

Performance Health System. The Commission on a High

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!